{"id":468,"date":"2026-08-28T06:56:05","date_gmt":"2026-08-28T06:56:05","guid":{"rendered":"https:\/\/nhdbio.com\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"ipamorelin-postoperative-ileus-randomized-trial-null-result","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/fr\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/","title":{"rendered":"Ipamorelin apr\u00e8s une chirurgie intestinale\u00a0: l'essai randomis\u00e9 et son crit\u00e8re d'\u00e9valuation principal nul"},"content":{"rendered":"
Ipamorelin a \u00e9t\u00e9 test\u00e9 dans le cadre d\u2019une \u00e9tude de r\u00e9section intestinale multicentrique, en double aveugle et contr\u00f4l\u00e9e par placebo. Le r\u00e9sultat m\u00e9dian \u00e9tait num\u00e9riquement favorable \u00e0 l'ipamor\u00e9line, mais la diff\u00e9rence n'\u00e9tait pas statistiquement significative et les auteurs n'ont signal\u00e9 aucun r\u00e9sultat cl\u00e9 ou secondaire significatif en mati\u00e8re d'efficacit\u00e9.<\/p>
Ce que montre le dossier<\/h2>
Les patients 117 ont \u00e9t\u00e9 recrut\u00e9s et 114 est entr\u00e9 dans les analyses de s\u00e9curit\u00e9 et d'intention de traiter modifi\u00e9es.<\/li>
Le temps m\u00e9dian jusqu'\u00e0 un repas solide tol\u00e9r\u00e9 \u00e9tait de 25.3 heures avec l'ipamor\u00e9line et de 32.6 heures avec le placebo.<\/li>
La comparaison primaire n'\u00e9tait pas significative : p = 0.15.<\/li><\/ul><\/div><\/div>Illustration \u00e9ditoriale originale du contexte de recherche. Il ne s'agit pas d'une figure d'\u00e9tude, d'une image de patient, d'une photographie du produit fourni ou d'une repr\u00e9sentation du mat\u00e9riel d'essai.<\/figcaption><\/figure>
Dossier d'\u00e9tudes<\/h2>
Une diff\u00e9rence num\u00e9rique sur sept heures peut sembler convaincante lorsqu\u2019elle est d\u00e9tach\u00e9e de l\u2019incertitude. Le test statistique pr\u00e9d\u00e9fini est ce qui d\u00e9termine si l'essai a distingu\u00e9 les groupes au-del\u00e0 du hasard selon sa conception\u00a0; ici, ce n'est pas le cas.<\/p>
Conception<\/strong>Phase multicentrique, en double aveugle, contr\u00f4l\u00e9e par placebo 2<\/span><\/div>
Population analys\u00e9e<\/strong>114<\/span><\/div>
Crit\u00e8re d'\u00e9valuation principal<\/strong>D\u00e9lai de tol\u00e9rance \u00e0 un repas solide standardis\u00e9<\/span><\/div>
R\u00e9sultat m\u00e9dian<\/strong>Horaires 25.3 vs 32.6<\/span><\/div>
R\u00e9sultat statistique<\/strong>p = 0.15; pas significatif<\/span><\/div><\/div><\/div>
R\u00e9sultats en contexte<\/h2>
Des \u00e9v\u00e9nements ind\u00e9sirables survenus pendant le traitement ont \u00e9t\u00e9 rapport\u00e9s dans le groupe 87.5% du groupe ipamorelin et dans le groupe 94.8% des participants au placebo. Il s'agissait d'une population de patients hospitalis\u00e9s postop\u00e9ratoires recevant un r\u00e9gime intraveineux d\u00e9fini, elle ne peut donc pas \u00eatre g\u00e9n\u00e9ralis\u00e9e \u00e0 d'autres voies ou contextes.<\/p>
Les travaux pr\u00e9cliniques sur la s\u00e9lectivit\u00e9 des r\u00e9cepteurs expliquent pourquoi l'ipamor\u00e9line a \u00e9t\u00e9 \u00e9tudi\u00e9e en tant qu'agoniste des r\u00e9cepteurs de la ghr\u00e9line. La plausibilit\u00e9 m\u00e9caniste ne garantissait pas un crit\u00e8re d'\u00e9valuation clinique positif.<\/p>
Ce \u00e0 quoi cette \u00e9tude ne peut pas r\u00e9pondre<\/h2>
L'essai \u00e9tait de petite taille et incluait des conditions chirurgicales h\u00e9t\u00e9rog\u00e8nes.<\/p>
Le protocole publi\u00e9 ne valide pas une utilisation non intraveineuse ni un lot de recherche sur catalogue.<\/p>","protected":false},"excerpt":{"rendered":"
Ipamorelin a \u00e9t\u00e9 test\u00e9 dans le cadre d\u2019une \u00e9tude de r\u00e9section intestinale multicentrique, en double aveugle et contr\u00f4l\u00e9e par placebo. Le r\u00e9sultat m\u00e9dian \u00e9tait num\u00e9riquement favorable \u00e0 l'ipamor\u00e9line, mais la diff\u00e9rence n'\u00e9tait pas statistiquement significative et les auteurs n'ont signal\u00e9 aucun r\u00e9sultat cl\u00e9 ou secondaire significatif en mati\u00e8re d'efficacit\u00e9.<\/p>","protected":false},"author":1,"featured_media":633,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"341","pim_article_type":"Published study case","pim_evidence_level":"Randomized phase 2 human trial; primary endpoint not met","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"Randomized ipamorelin study after bowel resection\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25331030\/\",\"note\":\"Primary phase 2 trial; PMID 25331030.\"},{\"title\":\"Ipamorelin receptor-selectivity study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9849822\/\",\"note\":\"Preclinical pharmacology; PMID 9849822.\"},{\"title\":\"FDA list of bulk substances with significant safety concerns\",\"url\":\"https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks\",\"note\":\"Current FDA ipamorelin safety and characterization summary.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-468","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"\n
Ipamorelin After Surgery: Randomized Trial Results<\/title>\n<meta name=\"description\" content=\"Ipamorelin was tested in a multicenter, double-blind, placebo-controlled bowel-resection study. The median result numerically favored ipamorelin, but the d\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/fr\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipamorelin After Bowel Surgery: The Randomized Trial and Its Null Primary Endpoint\" \/>\n<meta property=\"og:description\" content=\"Ipamorelin was tested in a multicenter, double-blind, placebo-controlled bowel-resection study. The median result numerically favored ipamorelin, but the d\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/fr\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ipamorelin-postoperative-ileus-randomized-trial-null-result-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Ipamorelin After Bowel Surgery: The Randomized Trial and Its Null Primary Endpoint\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result\\\/\"},\"wordCount\":251,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result-featured-v2.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result\\\/\",\"name\":\"Ipamorelin After Surgery: Randomized Trial Results\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"Ipamorelin was tested in a multicenter, double-blind, placebo-controlled bowel-resection study. The median result numerically favored ipamorelin, but the d\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ipamorelin-postoperative-ileus-randomized-trial-null-result\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ipamorelin After Bowel Surgery: The Randomized Trial and Its Null Primary Endpoint\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/fr\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ipamorelin apr\u00e8s la chirurgie\u00a0: r\u00e9sultats d\u2019essais randomis\u00e9s","description":"Ipamorelin a \u00e9t\u00e9 test\u00e9 dans le cadre d\u2019une \u00e9tude de r\u00e9section intestinale multicentrique, en double aveugle et contr\u00f4l\u00e9e par placebo. Le r\u00e9sultat m\u00e9dian \u00e9tait num\u00e9riquement favorable \u00e0 l'ipamor\u00e9line, mais le d\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/fr\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/","og_locale":"fr_FR","og_type":"article","og_title":"Ipamorelin After Bowel Surgery: The Randomized Trial and Its Null Primary Endpoint","og_description":"Ipamorelin was tested in a multicenter, double-blind, placebo-controlled bowel-resection study. The median result numerically favored ipamorelin, but the d\u2026","og_url":"https:\/\/nhdbio.com\/fr\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:05+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ipamorelin-postoperative-ileus-randomized-trial-null-result-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u00c9crit par":"NHD Technical Team","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Ipamorelin After Bowel Surgery: The Randomized Trial and Its Null Primary Endpoint","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/"},"wordCount":251,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ipamorelin-postoperative-ileus-randomized-trial-null-result-featured-v2.webp","articleSection":["Published Study Reviews"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/","url":"https:\/\/nhdbio.com\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/","name":"Ipamorelin apr\u00e8s la chirurgie\u00a0: r\u00e9sultats d\u2019essais randomis\u00e9s","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ipamorelin-postoperative-ileus-randomized-trial-null-result-featured-v2.webp","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"Ipamorelin a \u00e9t\u00e9 test\u00e9 dans le cadre d\u2019une \u00e9tude de r\u00e9section intestinale multicentrique, en double aveugle et contr\u00f4l\u00e9e par placebo. Le r\u00e9sultat m\u00e9dian \u00e9tait num\u00e9riquement favorable \u00e0 l'ipamor\u00e9line, mais le d\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ipamorelin-postoperative-ileus-randomized-trial-null-result-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ipamorelin-postoperative-ileus-randomized-trial-null-result-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/ipamorelin-postoperative-ileus-randomized-trial-null-result\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Ipamorelin After Bowel Surgery: The Randomized Trial and Its Null Primary Endpoint"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mati\u00e8res premi\u00e8res peptidiques et synth\u00e8se sur mesure","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"\u00c9quipe technique NHD","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"L'\u00e9quipe technique NHD maintient la documentation du catalogue d'utilisation de la recherche et les r\u00e9sum\u00e9s des preuves. Les articles examin\u00e9s renvoient \u00e0 des articles \u00e9valu\u00e9s par des pairs, \u00e0 des registres d'essais et \u00e0 des dossiers r\u00e9glementaires, conservent les r\u00e9sultats nuls et les limites des \u00e9tudes, et distinguent les interventions publi\u00e9es des documents du catalogue. Le dessin assist\u00e9 par AI peut \u00eatre utilis\u00e9 pour la structure\u00a0; les liens vers les sources et les limites des preuves restent visibles. Ce travail ne constitue pas un examen ind\u00e9pendant par des pairs ni un avis m\u00e9dical.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/fr\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/468","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/comments?post=468"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/468\/revisions"}],"predecessor-version":[{"id":508,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/468\/revisions\/508"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media\/633"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media?parent=468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/categories?post=468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/tags?post=468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Un](\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png\")